Dresden01. True, someone with the credentials that he has would not get involved with this company and associate himself with it if there was not something of significance in development and there is a great chance of success. Same holds for all of the others that have joined as of late too. The team that has been put together is very impressive. The PR's indicate that testing has been positive and is moving forward at a rapid rate. This company is very much under the radar. One of their competitors that is also a development company is Aratana Therapuetics(PETX). They have a similar OS and is currently at over $6/share. So this is radically undervalued. GL. ALL IMO.
News 
Market Data 
Discover 
